Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 57 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8124592

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  2. US 8124105

    Compositions, methods and kits relating to poxvirus subunit vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  3. US 8114852

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted

  4. US 8114848

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted

  5. US 8110352

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  6. US 8110192

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  7. US 8110681

    Compounds for the treatment of spinal muscular atrophy and other uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  8. US 8106027

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  9. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  10. US 8101380

    Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  11. US 8101172

    Solenopsis invicta virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  12. US 8093343

    Nitric oxide-releasing diazeniumdiolated compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  13. US 8088729

    Anti-viral griffithsin compounds, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  14. US 8088379

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  15. US 8088787

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  16. US 8084594

    H2N3 influenza A viruses and methods of use

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  17. US 8084199

    Method of diagnosing poor survival prognosis colon cancer using microRNA-21

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  18. US 8076100

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  19. US 8075900

    Melanoma associated peptide analogues and vaccines against melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  20. US 8075903

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  21. US 8071113

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  22. US 8071084

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  23. US 8071746

    Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  24. US 8067530

    Scytovirin domain 1 related polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.